Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
7.54
+0.13 (1.75%)
Nov 4, 2024, 4:00 PM EST - Market closed
Adverum Biotechnologies Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -99.86 | -117.17 | -154.54 | -145.54 | -117.51 | -64.49 | |
Depreciation & Amortization | 4.47 | 5.64 | 6.53 | 4.65 | 4.16 | 1.57 | |
Loss (Gain) From Sale of Assets | 0.05 | 0.05 | 0.12 | - | - | - | |
Asset Writedown & Restructuring Costs | 0.22 | 0.22 | 2.12 | 1.06 | - | - | |
Loss (Gain) From Sale of Investments | -1.04 | -1.94 | -0.88 | 2.77 | 0.52 | -1.27 | |
Stock-Based Compensation | 16.65 | 17.57 | 20.08 | 25.19 | 20.39 | 9.9 | |
Other Operating Activities | 7.42 | 13.03 | 2.62 | -0.03 | 0.42 | 0.06 | |
Change in Accounts Payable | 0.46 | -0.37 | 0.85 | -1.61 | 1.59 | -0.65 | |
Change in Other Net Operating Assets | -16.71 | -7.95 | 15 | 5.67 | 11.14 | 5.71 | |
Operating Cash Flow | -88.33 | -90.9 | -108.09 | -107.83 | -79.29 | -49.17 | |
Capital Expenditures | -0.79 | -0.81 | -11.82 | -15.12 | -11.84 | -19.25 | |
Investment in Securities | -15.24 | 97.68 | 153.54 | 93.83 | -268.32 | -48.83 | |
Investing Cash Flow | -16.04 | 96.88 | 141.72 | 78.71 | -280.17 | -68.07 | |
Long-Term Debt Repaid | - | - | - | -0.24 | -0.06 | -0.11 | |
Net Debt Issued (Repaid) | - | - | - | -0.24 | -0.06 | -0.11 | |
Issuance of Common Stock | 120.01 | 0.49 | 0.61 | 2.64 | 358.09 | 29.77 | |
Repurchase of Common Stock | - | - | - | - | -2.04 | -1.47 | |
Other Financing Activities | -0.18 | -0.42 | - | - | - | - | |
Financing Cash Flow | 119.83 | 0.07 | 0.61 | 2.4 | 355.99 | 28.19 | |
Net Cash Flow | 15.46 | 6.04 | 34.24 | -26.73 | -3.47 | -89.05 | |
Free Cash Flow | -89.12 | -91.71 | -119.91 | -122.95 | -91.14 | -68.42 | |
Free Cash Flow Margin | - | -2547.50% | - | -1639.39% | - | -27366.80% | |
Free Cash Flow Per Share | -6.18 | -9.10 | -12.08 | -12.54 | -10.70 | -10.67 | |
Levered Free Cash Flow | -54.43 | -60.69 | -72.63 | -80.16 | -54.76 | -52.12 | |
Unlevered Free Cash Flow | -54.43 | -60.69 | -72.63 | -80.16 | -54.76 | -52.12 | |
Change in Net Working Capital | 7.14 | 5.74 | -6.52 | 4.21 | -6.25 | 1.51 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.